Star Scientific IND Blocks Supplement Marketing Options – FDA

An FDA warning letter deems Star Scientific’s CigRx and Anatabloc supplements unapproved drugs due to multiple issues, including claims. The firm’s approved IND study for the ingredient also prevents its use in supplements, the agency says.

More from United States

More from North America